Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
G-CSF for repeated implantation failure in assisted reproduction
ChiCTR2100052078Phase 4Recruiting
- Sponsor
- Second Hospital of Lanzhou University
- Start
- Aug 2022
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Recurrent Implantation Failure (RIF) comparing G-CSF group with Placebo group (2 arms). Primary endpoint: Clinical pregnancy rate. Started Aug 2022; status: recruiting.
02
Drugs
filgrastim
03
Conditions
Recurrent Implantation Failure (RIF)
Beyond the preview
Go deeper on ChiCTR2100052078.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100052078.